Xue Xiajuan, Jian Chao, Fang Yicong, Luo Lixiong, Guo Yinzong, Ling Bijuan, Cai Mingzhi
Colorectal Surgery, Zhangzhou Municipal Hospital Affiliated of Fujian Medical University, Xiangcheng, Zhangzhou, Fujian.
Internal Medicine ICU, Zhangzhou Municipal Hospital Affiliated of Fujian Medical University, Xiangcheng, Zhangzhou, Fujian.
J Minim Access Surg. 2024 Jan 1;20(1):55-61. doi: 10.4103/jmas.jmas_168_22. Epub 2023 Jul 5.
The objective is to investigate if laparoscopic-dominant abdominoperineal resection (LDAPR) with individualised levator ani resection inhibits local recurrence (LR) and prolongs survival as compared to laparoscopic abdominoperineal resection (APR).
Rectal cancer surgery cases were retrospectively identified from September 2014 to December 2019. LDAPR-treated group (55 patients) and the APR-treated group (71 patients) were included in the study. The operation time, circumferential resection margin (CRM), intraoperative tumor surgery (ITP), post-operative complications, the 2-year overall survival (OS) and LR were compared in the two groups.
The CRM and ITP were significantly reduced in the LDAPR as compared to the APR group (3.6% vs. 16.9%, t = 5.522, P = 0.019; 3.6% vs. 14.1%, t = 3.926, P = 0.048). In terms of post-operative complications, the incidence of urinary retention in LDAPR was significantly reduced than the APR group (10.9% vs. 25.4%, χ2 = 4.139, P = 0.041). Similarly, perineal pain at 6 months or 1 year after surgery was significantly down-regulated in LDAPR than in the APR group (72.7% vs. 88.7%, χ2 = 5.320, P = 0.021; 18.2% vs. 43.2%, χ2 = 8.288, P = 0.004). However, there was no statistically significant difference in the post-operative complications between the LDAPR and APR groups. Finally, LDAPR led to a significantly improved 2-year OS and a reduced LR compared to APR.
LDAPR reduces CMR, ITP and LR and simplified the perineum operation, subsequently protecting the pelvic autonomic nerves. Compared to the conventional APR, LDAPR is a promising procedure worth adopting for rectal cancer treatment.
探讨与腹腔镜腹会阴联合切除术(APR)相比,个体化肛提肌切除术的腹腔镜主导腹会阴联合切除术(LDAPR)是否能抑制局部复发(LR)并延长生存期。
回顾性分析2014年9月至2019年12月期间的直肠癌手术病例。研究纳入LDAPR治疗组(55例患者)和APR治疗组(71例患者)。比较两组的手术时间、环周切缘(CRM)、术中肿瘤操作(ITP)、术后并发症、2年总生存率(OS)和LR。
与APR组相比,LDAPR组的CRM和ITP显著降低(3.6%对16.9%,t = 5.522,P = 0.019;3.6%对14.1%,t = 3.926,P = 0.048)。在术后并发症方面,LDAPR组尿潴留的发生率显著低于APR组(10.9%对25.4%,χ2 = 4.139,P = 0.041)。同样,LDAPR组术后6个月或1年时的会阴部疼痛较APR组显著减轻(72.7%对88.7%,χ2 = 5.320,P = 0.021;18.2%对43.2%,χ2 = 8.288,P = 0.004)。然而,LDAPR组和APR组术后并发症的差异无统计学意义。最后,与APR相比,LDAPR使2年OS显著提高,LR降低。
LDAPR可降低CMR、ITP和LR,简化会阴手术,进而保护盆腔自主神经。与传统APR相比,LDAPR是一种值得在直肠癌治疗中采用的有前景的术式。